Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
349 EUR | +0,72% | -7,18% | -2,92% |
24/04 | LE OPINIONI DEGLI ANALISTI DEL GIORNO : Sanlorenzo, Kering, Acerinox, Saipem, Enagas, UBS, Adidas, Galp Energia, Fraport... | |
17/04 | VIRBAC : Un inizio sano per il 2024; prospettive ribadite |
Attività
- farmaci per animali domestici: disinfestanti, vaccini, antibiotici, anestetici, antinfiammatori, prodotti per la cura della bocca/dentale, prodotti oftalmologici e dermatologici destinati a cani, gatti, cavalli, uccelli, roditori, ecc. Il Gruppo offre anche alimenti e chip per l'identificazione elettronica;
- farmaci per il bestiame: disinfestanti e antibiotici destinati a bovini, ovini, suini, pollame, ecc.
Le vendite nette sono distribuite geograficamente come segue: Francia (15,8%), Europa (24,9%), Asia (17,5%), America Latina (16,2%), Nord America (13,3%), Pacifico (9,7%), Africa e Medio Oriente (2,6%).
Numero di dipendenti: 5 459
Vendite per attività
EUR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Farm Animals - Other Ruminants
16,7
%
| 204 | 16,8 % | 208 | 16,7 % | +2,11% |
Companion Animals - Specialties
11,2
%
| 133 | 10,9 % | 139 | 11,2 % | +4,97% |
Companion Animals - Specialized Petfood
9,6
%
| 99 | 8,1 % | 119 | 9,6 % | +21,22% |
Companion Animals - Others
9,6
%
| 122 | 10,1 % | 119 | 9,6 % | -2,53% |
Companion Animals - Parasiticides
9,4
%
| 123 | 10,1 % | 117 | 9,4 % | -5,13% |
Companion Animals - Antibiotics/Dermatology
9,1
%
| 111 | 9,1 % | 114 | 9,1 % | +2,89% |
Farm Animals - Bovine Antibiotics
7,7
%
| 86 | 7,1 % | 96 | 7,7 % | +11,63% |
Companion Animals - Immunology
6,3
%
| 85 | 7,0 % | 79 | 6,3 % | -7,39% |
Farm Animals - Bovine Parasiticides
6,1
%
| 76 | 6,2 % | 76 | 6,1 % | +0,53% |
Farm Animals - Other Pig/Poultry
3,5
%
| 37 | 3,0 % | 44 | 3,5 % | +20,82% |
Farm Animals - Aquaculture
3,0
%
| 44 | 3,6 % | 37 | 3,0 % | -15,58% |
Companion Animals - Equine
2,7
%
| 34 | 2,8 % | 33 | 2,7 % | -0,30% |
Other
2,7
%
| 32 | 2,6 % | 33 | 2,7 % | +4,40% |
Farm Animals - Pig/Poultry Antibiotics
2,5
%
| 32 | 2,6 % | 31 | 2,5 % | -2,81% |
Vendite per regione
EUR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Europe (excluding France)
26,2
%
| 303 | 24,9 % | 327 | 26,2 % | +7,96% |
Latin America
17,1
%
| 197 | 16,2 % | 214 | 17,1 % | +8,53% |
Asia
16,4
%
| 213 | 17,5 % | 204 | 16,4 % | -4,16% |
France
15,4
%
| 192 | 15,8 % | 192 | 15,4 % | +0,16% |
North America
13,2
%
| 162 | 13,3 % | 165 | 13,2 % | +1,87% |
Pacific
9,3
%
| 118 | 9,7 % | 116 | 9,3 % | -1,57% |
Africa & Middle East
2,4
%
| 32 | 2,7 % | 30 | 2,4 % | -8,64% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Sébastien Huron
CEO | Chief Executive Officer | 54 | 01/01/06 |
Habib Ramdani
DFI | Director of Finance/CFO | 48 | 01/02/16 |
Sophie Favini
COO | Chief Operating Officer | - | 01/07/23 |
Chief Tech/Sci/R&D Officer | - | 01/05/94 | |
Sandrine Brunel
IRO | Public Communications Contact | - | 01/11/98 |
Michel Garaudet
IRC | Investor Relations Contact | 69 | 01/12/02 |
Marc Bistuer
PRN | Corporate Officer/Principal | 63 | 15/12/20 |
Human Resources Officer | - | 01/05/15 | |
Nathalie Pollet
SAM | Sales & Marketing | - | 01/01/93 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 65 | 01/01/11 | |
Philippe Capron
BRD | Director/Board Member | 64 | 01/01/04 |
Chairman | 59 | 01/01/98 | |
Director/Board Member | 63 | 01/01/95 | |
Director/Board Member | 53 | 18/06/19 | |
Director/Board Member | 30 | 05/09/17 | |
Sylvie Gueguen
BRD | Director/Board Member | 59 | 30/10/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 8 458 000 | 4 193 415 ( 49,58 %) | 88 281 ( 1,044 %) | 49,58 % |
Partecipazioni
Nome | Azioni | % | Valorizzazione |
---|---|---|---|
VIRBAC 0.19% | 15 852 | 0.19% | 5 923 576 $ |
Coordinate società
Società del gruppo
Nome | Categoria e settore |
---|---|
Bio Veto Tests SA
Bio Veto Tests SA Pharmaceuticals: MajorHealth Technology Part of Virbac SA, Bio Veto Tests SA is a French company that develops vaccines against viral and parasitic diseases in companion animals. The private company is based in Sanary sur Mer, France. Bio Veto Tests was acquired by Virbac SA on May 07, 2003. |
Pharmaceuticals: Major
|
Virbac Nutrition SAS
Virbac Nutrition SAS Food: Specialty/CandyConsumer Non-Durables Part of Virbac SA, Virbac Nutrition SAS is a French company that manufactures and wholesales pet food. The private company is based in Vauvert, France. The company was founded in 1987. Philippe Domptail has been the CEO of the company since 2011. |
Food: Specialty/Candy
|
Virbac (Australia) Pty Ltd.
Virbac (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Virbac SA, Virbac (Australia) Pty Ltd. is an Australian company that manufactures veterinary pharmaceuticals and vaccines. The private company is based in Milperra, Australia. |
Pharmaceuticals: Major
|
Virbac RSA (Pty) Ltd.
| |
Virbac Animal Health India Pvt Ltd.
| |
Virbac Ltd.
Virbac Ltd. Medical DistributorsDistribution Services Part of Virbac SA, Virbac Ltd. is a British company that wholesales pharmaceutical products. The private company is based in Bury St. Edmunds, UK. Founded in 1986. |
Medical Distributors
|
Virbac New Zealand Ltd.
Virbac New Zealand Ltd. Pharmaceuticals: MajorHealth Technology Part of Virbac SA, Virbac New Zealand Ltd. is a New Zealander company that manufactures medicines for animals. The private company is based in Auckland, New Zealand. |
Pharmaceuticals: Major
|
Virbac Mexico SA de CV
Virbac Mexico SA de CV Pharmaceuticals: MajorHealth Technology Part of Virbac SA, Virbac Mexico SA de CV is a Mexican pharmaceutical company that manufactures pharmaceutical products. The private company is based in Guadalajara, Mexico. |
Pharmaceuticals: Major
|
Virbac Danmark A/S
|
Settore
Vendite per attività
Vendite per regione
Revisioni EPS
Fatturato trimestrale - Indice di sorpresa
Variaz. 1 gen. | Capi. | |
---|---|---|
-2,92% | 3,12 Mrd | |
-19,73% | 72,39 Mrd | |
-11,01% | 6,54 Mrd | |
+15,88% | 3,43 Mrd | |
-0,68% | 1,4 Mrd | |
-17,27% | 1,34 Mrd | |
-2,73% | 1,26 Mrd | |
-28,16% | 1,2 Mrd | |
-14,67% | 1,12 Mrd | |
-5,37% | 990 Mln |
- Borsa valori
- Azioni
- Azione VIRP
- Società Virbac